Onyvia Biolabs rebrands from Greenlight Clinical Laboratories
Onyvia Biolabs, formerly known as GreenLight Clinical Laboratories, has officially separated from GreenLight Clinical CRO and rebranded.
Founded in June 2020, GLC Laboratories opened as a central laboratory offering safety testing, specialty testing, and bioanalytical services. Now, Onyvia Biolabs is building upon the solid foundation established by GLC Laboratories to provide an even better service to the biotech industry.
We are thrilled to be launching our new brand identity and website as Onyvia Biolabs” said Dr Sally Mahmoud, Laboratory Director. “Our Mission is to provide clarity and transparency into clinical research with innovative laboratory solutions that help ensure the accuracy of trial results.”
Onyvia Biolabs provides high-quality laboratory testing services for pharmaceutical companies, medical device manufacturers, and other biotech organisations. Their team of experts includes PhD-holding scientists, a PhD Clinical Pathologist and multilingual project managers. Their innovative technologies and processes, such as PK Testing and fully automated biomarker testing, enable the team at Onyvia Biolabs to deliver accurate results quickly and efficiently to a global audience.
With the launch of Onyvia Biolabs comes a range of new features including a Flow cytometry Lab, enhanced security protocols, and even faster turnaround times for trial results.
“We believe that our rebranding will help us reach more clients while providing them with a superior service” Dr Mahmoud added. “At Onyvia Biolabs, we strive for excellence in everything we do.”
By Rebranding from GreenLight Clinical Laboratories, this organisation is taking its commitment to providing reliable data-driven insights for decision-making even further. With enhanced security protocols and faster turnaround times for trial results – along with additional services – this rebranding marks the beginning of an exciting journey toward success.
About Onyvia Biolabs
Prove Clinical Laboratory is a clinical trial laboratory service offering routine central clinical safety testing, and customisable biomarker analysis, bioanalytical, PK/PD and histopathology services. Onyvia Biolabs is based in the CBD area in Sydney, NSW. Since June 2020 has been servicing the Biotech industry with seamless clinical trial central lab solutions with increased efficiency and collaboration.
For more information, please contact:
Michelle Granzow
Marketing Manager
Onyvia Biolabs
E: marketing@onyviabiolabs.com
